1. Home
  2. VCEL

VCEL

Vericel Corporation

as 02-21-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 1989 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 1997
Target Price: $63.29 AVG Volume (30 days): 341.7K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.07 EPS Growth: N/A
52 Week Low/High: $39.12 - $63.00 Next Earning Date: 02-27-2025
Revenue: $226,844,000 Revenue Growth: 22.48%
Revenue Growth (this year): 23.08% Revenue Growth (next year): 21.58%

VCEL Daily Stock ML Predictions

Stock Insider Trading Activity of Vericel Corporation (VCEL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
SIEGAL JONATHAN VCEL Principal Accounting Officer Feb 18 '25 Sell $56.72 1,710 $96,991.20 1,206
MCLAUGHLIN KEVIN F VCEL Director Feb 12 '25 Sell $55.45 7,000 $388,250.00 11,900
SIEGAL JONATHAN VCEL Principal Accounting Officer Feb 5 '25 Sell $61.99 1,092 $67,693.08 1,206
ZERBE ROBERT L MD VCEL Director Feb 5 '25 Sell $62.50 2,500 $156,250.00 26,595
SIEGAL JONATHAN VCEL Principal Accounting Officer Jan 28 '25 Sell $61.99 3,908 $242,256.92 1,206
Wotton Paul K VCEL Director Dec 4 '24 Sell $58.72 2,600 $152,672.00 27,402
Hopper Jonathan Mark VCEL Chief Medical Officer Dec 2 '24 Sell $58.72 10,000 $587,200.00 58,371

Share on Social Networks: